A class action lawsuit has been filed against O-I Glass and its executives for allegedly making false and misleading statements about the company's Fit to Win program, including delays in cost savings and operational issues. The lawsuit covers investors who bought O-I Glass securities between March 14, 2025, and July 28, 2026. The case arose after O-I Glass revealed on July 28, 2026, that it would lower its 2026 financial guidance and adjust 2027 targets, causing its stock price to drop about 15%. Investors affected are advised to contact the law firm before the December 28, 2026 deadline to participate in the lawsuit.
Regarding the class action lawsuit against O-I Glass, here is Pluang's Basic Materials sector market snapshot as of Oct 30, 2026 23:41 WIB: Out of 83 priced US stocks, 17 rose and 65 fell. Notable movers include USAS at USD 2.86 with a -6.84% change and 100% buy order activity, ALM at USD 8.68 down 6.72%, and CDE at USD 13.12 down 6.55%.
FreightCar America disclosed on October 19, 2026, that it removed 1,285 railcars from its backlog after a customer was unlikely to fulfill contractual obligations, causing its stock to drop 31.4% to $4.02. This sharp decline has led Glancy Prongay Wo...
FirstCash Holdings, Inc. shares fell 14.75% following the October 22, 2026 disclosure of its third quarter financial results, which showed a 28% year-over-year decline in operating income for its American First Finance segment to $33 million. The com...
The global screw compressors market is projected to grow from $13.97 billion in 2026 to $18.38 billion by 2031, at a CAGR of 5.66%. Growth is fueled by rising industrial automation, energy-efficiency regulations, and demand in manufacturing, oil and ...
Enova International's stock fell 23.43% after the company withdrew its application to acquire Grasshopper Bancorp and become a bank holding company. The withdrawal was due to unclear regulatory standards and political pressures cited by Enova. This s...
The global dialysis machines market is forecasted to grow from $17.89 billion in 2026 to $31.54 billion by 2035, at a CAGR of 6.5%. Growth is fueled by rising chronic kidney disease cases, expanding dialysis infrastructure, and innovations like home ...
